Growing number of hospitalizations may have been caused by counterfeit Botox, warns FDA

In this emergency podcast recorded on Friday, April 21, former prosecutor Sam Louis, pharmaceutical wholesale and traceability expert Ron Bone, and PSM's executive director Shabbir Imber Safdar discuss what is likely happening in the case now, and talk about previous Botox cases.

 

What are the investigators likely hunting for at this moment, and what are we likely to see next?